Ding N - Search Results

1

Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy.

Shi L, Wang J, Ding N, Zhang Y, Zhu Y, Dong S, Wang X, Peng C, Zhou C, Zhou L, Li X, Shi H, Wu W, Long X, Wu C, Liao W. Shi L, et al. Among authors: ding n. Nat Commun. 2019 Nov 28;10(1):5421. doi: 10.1038/s41467-019-13204-3. Nat Commun. 2019. PMID: 31780645 Free PMC article.

2

NEK4 kinase regulates EMT to promote lung cancer metastasis.

Ding NH, Zhang L, Xiao Z, Rong ZX, Li Z, He J, Chen L, Ou DM, Liao WH, Sun LQ. Ding NH, et al. J Cell Mol Med. 2018 Dec;22(12):5877-5887. doi: 10.1111/jcmm.13857. Epub 2018 Sep 24. J Cell Mol Med. 2018. PMID: 30247800 Free PMC article.

3

Yes-associated protein expression in paired primary and local recurrent breast cancer and its clinical significance.

Ding N, Huang T, Yuan J, Mao J, Duan Y, Liao W, Xiao Z. Ding N, et al. Curr Probl Cancer. 2019 Oct;43(5):429-437. doi: 10.1016/j.currproblcancer.2018.12.005. Epub 2019 Jan 17. Curr Probl Cancer. 2019. PMID: 30678988

4

Prognostic Factors for Luminal B-like Breast Cancer.

Ding NH, Liu CF, Hu C, Yuan JQ, Liao WH, Xiao Z. Ding NH, et al. Curr Med Sci. 2019 Jun;39(3):396-402. doi: 10.1007/s11596-019-2049-8. Epub 2019 Jun 17. Curr Med Sci. 2019. PMID: 31209809

5

Identification and characterization of DNAzymes targeting DNA methyltransferase I for suppressing bladder cancer proliferation.

Wang X, Zhang L, Ding N, Yang X, Zhang J, He J, Li Z, Sun LQ. Wang X, et al. Among authors: ding n. Biochem Biophys Res Commun. 2015 May 29;461(2):329-33. doi: 10.1016/j.bbrc.2015.04.033. Epub 2015 Apr 15. Biochem Biophys Res Commun. 2015. PMID: 25888794

6

Systemic immune-inflammation index as a prognostic marker in HER2-positive breast cancer patients undergoing trastuzumab therapy.

Pang J, Ding N, Yin N, Xiao Z. Pang J, et al. Among authors: ding n. Sci Rep. 2024 Mar 19;14(1):6578. doi: 10.1038/s41598-024-57343-0. Sci Rep. 2024. PMID: 38503890 Free PMC article.

7

EIF2A promotes cell survival during paclitaxel treatment in vitro and in vivo.

Chen L, He J, Zhou J, Xiao Z, Ding N, Duan Y, Li W, Sun LQ. Chen L, et al. Among authors: ding n. J Cell Mol Med. 2019 Sep;23(9):6060-6071. doi: 10.1111/jcmm.14469. Epub 2019 Jun 18. J Cell Mol Med. 2019. PMID: 31211507 Free PMC article.

8

Roles of neutrophil/lymphocyte ratio in prognosis and in differentiation of potential beneficiaries in HER2-positive breast cancer with trastuzumab therapy.

Ding N, Huang J, Li N, Yuan J, Wang S, Xiao Z. Ding N, et al. BMC Cancer. 2020 Mar 19;20(1):235. doi: 10.1186/s12885-020-06750-3. BMC Cancer. 2020. PMID: 32192443 Free PMC article.

9

Molecular mechanisms and treatment of radiation-induced lung fibrosis.

Ding NH, Li JJ, Sun LQ. Ding NH, et al. Curr Drug Targets. 2013 Oct;14(11):1347-56. doi: 10.2174/13894501113149990198. Curr Drug Targets. 2013. PMID: 23909719 Free PMC article. Review.

10

Platelet/Lymphocyte Ratio Is Superior to Neutrophil/Lymphocyte Ratio as a Predictor of Chemotherapy Response and Disease-free Survival in Luminal B-like (HER2^-) Breast Cancer.

Hu Y, Wang S, Ding N, Li N, Huang J, Xiao Z. Hu Y, et al. Among authors: ding n. Clin Breast Cancer. 2020 Aug;20(4):e403-e409. doi: 10.1016/j.clbc.2020.01.008. Epub 2020 Jan 30. Clin Breast Cancer. 2020. PMID: 32201163

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,832 results

Search Page